| # | Drug | Count |
|---|---|---|
| 0 | CANAGLIFLOZIN | 50 |
| 1 | ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | 25 |
| 2 | FUROSEMIDE | 22 |
| 3 | INSULIN GLARGINE | 17 |
| 4 | ASPIRIN | 16 |
| 5 | METFORMIN | 16 |
| 6 | ASPIRIN 325 MG | 14 |
| 7 | ASPIRIN 81 MG | 14 |
| 8 | INSULIN LISPRO | 14 |
| 9 | INSULIN | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | METHSCOPOLAMINE BROMIDE | 1 | 0.0069 |
| 1 | ETELCALCETIDE | 5 | 0.0017 |
| 2 | CANAGLIFLOZIN | 50 | 0.0017 |
| 3 | CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 3 | 0.0017 |
| 4 | DOCUSATE SODIUM 50 MG AND SENNOSIDES 8.6 MG | 1 | 0.0012 |
| 5 | LANTHANUM CARBONATE | 6 | 0.0012 |
| 6 | HUMAN INSULIN | 8 | 0.0011 |
| 7 | MIGLITOL | 1 | 0.0010 |
| 8 | DAPRODUSTAT | 2 | 0.0010 |
| 9 | DANTROLENE SODIUM | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Insulin Analog [EPC] | 49 |
| 1 | Loop Diuretic [EPC] | 24 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 20 |
| 3 | Insulin [EPC] | 16 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 16 |
| 5 | Corticosteroid [EPC] | 14 |
| 6 | Sulfonylurea [EPC] | 14 |
| 7 | Proton Pump Inhibitor [EPC] | 12 |
| 8 | GLP-1 Receptor Agonist [EPC] | 11 |
| 9 | Dihydropyridine Calcium Channel Blocker [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 2 | 0.0009 |
| 1 | Leptin Analog [EPC] | 1 | 0.0008 |
| 2 | Vitamin D2 Analog [EPC] | 5 | 0.0007 |
| 3 | Phosphate Binder [EPC] | 2 | 0.0007 |
| 4 | alpha-Glucosidase Inhibitor [EPC] | 2 | 0.0004 |
| 5 | Insulin [EPC] | 16 | 0.0003 |
| 6 | Vitamin D Analog [EPC] | 5 | 0.0003 |
| 7 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 8 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 9 | Parenteral Iron Replacement [EPC] | 3 | 0.0002 |